Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G ↓	Ingredients	Dosage	Form	Price
J01DC02	MAXIL 750	G	Cefuroxime - 750mg	750mg	Injectable dry powder	159,917 L.L
A01AB09	MICONAZ	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	229,093 L.L
J01MA12	MATADOR	G	Levofloxacin - 750mg	750mg	Tablet, film coated	1,126,140 L.L
A01AB09	MICOZOLE	G	Miconazole - 20mg/g	20mg/g	Gel	104,820 L.L
A01AB09	MYCOHEAL	G	Miconazole nitrate - 20mg/g	20mg/g	Gel	210,983 L.L
A07AA02	MEDISTAN	G	Nystatin - 500,000IU	500,000IU	Capsule	417,231 L.L
N06BA07	MODAFINIL ARROW	G	Modafinil - 100mg	100mg	Tablet	5,361,932 L.L
A07AA02	MEDISTAN	G	Nystatin - 500,000IU/5ml	500,000IU/5ml	Suspension	415,951 L.L
A07AA02	MEDISTAN	G	Nystatin - 200.000IU	200.000IU	Lozenge	418,511 L.L
N02BE01	MAKOACHE	G	Paracetamol - 1000mg/100ml	10mg/ml	Injectable solution	1,403,867 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
J01MA14	MOFLOXINE	G	Moxifloxacin (HCl) - 400mg/250ml	400mg/250ml	Injectable solution	1,638,144 L.L
S01EB09	MIOVISIN	G	Acetylcholine chloride - 20mg/2ml	20mg/2ml	Injectable powder for solution+solvent	6,449,100 L.L
A02BB01	MISOFAR	G	Misoprostol - 200mcg	200mcg	Tablet	1,546,763 L.L
A02BB01	MISOFAR	G	Misoprostol - 25mcg	25mcg	Tablet	1,855,846 L.L
J01RA	MEDSPIRAGYL	G	Metronidazole - 125mg, Spiramycin - 750,000IU		Tablet, scored	474,824 L.L
D10AF01	MEDACIN T	G	Clindamycin (phosphate) - 10mg/ml	10mg/ml	Solution	314,459 L.L
G04CA02	MINGO	G	Tamsulosin - 0.4mg	0.4mg	Capsule	673,201 L.L
N06CA02	MELIXITE	G	Flupentixol (dihydrochloride) - 0.5mg, Melitracen (HCl) - 10mg		Tablet, film coated	600,250 L.L
L01BA01	METHOTREXAT EBEWE	G	Methotrexate - 500mg	500mg	Injectable solution	1,842,408 L.L
D10AF02	MED-ERYTHROMYCIN 4%	G	Erythromycin - 40mg/ml	4%	Solution	235,492 L.L
R03DC03	MONTELUKAST ARROW LAB	G	Montelukast (sodium) - 5mg	5mg	Tablet, chewable	851,996 L.L
A02BC01	MEDIZOLE GP	G	Omeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	503,941 L.L
R03DC03	MONTELUKAST-SANDOZ	G	Montelukast (sodium) - 5mg	5mg	Tablet, chewable	1,139,034 L.L
J01DD04	MEDAXONUM	G	Ceftriaxone (disodium) (Vial) - 500mg, Lidocaine (ampoule) -	500mg	Injectable powder for solution+diluent	307,740 L.L
J01DD04	MEGION-A	G	Ceftriaxone - 0.5g/2ml, Lidocaine (ampoule) -	0.5g/2ml	Injectable powder + solvent	342,285 L.L
N02BE51	MAXIFEN	G	Paracetamol - 325mg, Ibuprofen - 400mg		Tablet, scored	225,254 L.L
R03DC03	MONTELUKAST ARROW LAB	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	978,317 L.L
S01EE01	MONOPROST	G	Latanoprost - 50mcg/ml	50mcg/ml	Drops solution	1,187,957 L.L